Suggestions
Nworah Ayogu
Medical Director, PillPack, Principal Medical Officer at Amazon
Nworah Ayogu is a prominent healthcare executive with extensive experience in digital health and innovative healthcare delivery models. Here's an overview of his career and accomplishments:
Professional Experience
Amazon: Nworah Ayogu held several key positions at Amazon:
- General Manager and Chief Medical Officer of Amazon Clinic (January 2022 - May 2024)12
- Chief Medical Officer of Amazon Pharmacy (November 2020 - November 2022)3
- Medical Director of PillPack (April 2020 - November 2020)3
During his tenure at Amazon, Dr. Ayogu played a crucial role in integrating PillPack, launching Amazon Pharmacy, building and launching Amazon Clinic, and integrating One Medical.1
Previous Roles: Before joining Amazon, Dr. Ayogu's career included:
- Associate Chief Medical Officer at Renew Health3
- Founding Medical Director and Director of Clinical Product at Cityblock Health3
- Associate at McKinsey & Company3
Education and Training
Dr. Ayogu has an impressive educational background:
- MD from Harvard Medical School4
- MBA from Harvard Business School4
- AB in Neurobiology from Harvard University3
- Internal Medicine Residency at Columbia University34
He is a board-certified internist.4
Achievements and Recognition
- Named one of Business Insider's 30 under 404
- Listed in Modern Healthcare's 50 most influential clinical executives4
- Served as a member of the White House Health Equity round table4
- Held faculty appointments at Harvard and NYU4
Current Position
As of May 2024, Dr. Ayogu announced his departure from Amazon to join Thrive Capital, a venture capital firm focused on internet, software, and technology companies.12 In his new role, he will be focusing exclusively on healthcare.1
Dr. Ayogu's career demonstrates a strong commitment to improving healthcare delivery through technology and innovation, with a particular emphasis on increasing access and quality of care.
Highlights
Today, we announced the closing of Thrive IX with over $5bn in commitments. At Thrive, we aim to be concentrated in both people and ideas. We are in a period of great technological innovation and breakthroughs, and with this new set of funds, we are excited to continue to partner with the category-defining companies of our generation.
I've been learning about a lot of great companies applying AI to identifying drug candidates and the commercialization space - but I'm becoming more and more interested in the layer between. All the work from candidate discovery to approval and more specifically the new infrastructure layers needed to unlock the data needed to drive the insights. Benchling is a great example of companies digitizing the collective knowledge of pharma R+D so that we can learn form our failures, our successes, and all of the steps inbetween. Interested to learn about others in the space as well
